Molecular You

What Molecular You does

Molecular You is a Vancouver-based precision health company founded in 2014 as a spin-off of the Personalized Medicine Initiative, operating a multi-omic biomarker testing platform that measures 250+ proteins and metabolites from a single low-volume blood draw. The core technology combines proteomics and metabolomics via liquid chromatography-mass spectrometry with Multiple Reaction Monitoring (MRM), achieving an average coefficient of variation of approximately 10% and requiring 9x less blood than leading direct-to-consumer competitors. AI algorithms interpret the resulting structured biomarker data against an extensive library of peer-reviewed scientific publications and clinical datasets, generating health scores across 7 biological systems, 27+ processes, and 15 disease categories, plus personalized recommendations for diet, lifestyle, and supplements.

The company sells through two channels: a direct-to-consumer e-commerce storefront (store.molecularyou.com) offering one-time test purchases with longitudinal re-test guidance every 3-12 months, and a B2B clinical channel delivered via a Provider Portal with monthly subscriptions for clinicians and EHR-compatible PDF reports. In the United States, the assay is distributed through a HealthQuest Esoterics Lab Developed Test partnership, making it eligible for insurance reimbursement. Specialized clinical modules address behavioral health (neurotransmitter pathway analysis for anxiety, depression, PTSD, cognitive decline) and functional medicine (chronic disease, autoimmune, cardiovascular, liver health, cancer-related pathways), with active commercial engagement in the longevity clinic segment.

Molecular You has raised approximately $21.4M across multiple rounds since 2016, including a $5M Series A in August 2025 led by Voloridge Health. The company is led by CEO Jim Kean (formerly founder of WellnessFX and architect of WebMD's consumer platform), with co-founders including Dr. Rob Fraser (CSO/President), Prof. David Wishart (CIO, University of Alberta metabolomics pioneer), Dr. Christoph Borchers (Chief Lab Analytics Officer), and board chair Dr. Pieter Cullis (UBC professor, lipid nanoparticle pioneer). The platform is expanding internationally via MOUs with South Korea's NKCL Bio Group (September 2025) and Japan's NPK Co., Ltd. (January 2026), and via a June 2026 collaboration with Evosep to standardize LC instrumentation across an international partner laboratory network. A next-generation assay expanding to 800+ biomarkers, including certain cancer diagnostics, is in development.

Name

Molecular You

Legal name

Molecular You Co

Website

https://molecularyou.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Molecular You is a Vancouver-based precision health company that provides multi-omic biomarker testing (proteomics and metabolomics) from a single blood draw, using AI to generate personalized health assessments for individual consumers and clinical providers across North America and Asia.

Ownership category

akta.pro rank

Product category

Preventive Health Diagnostics

NAICS

Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Biomarker Discovery & Validation (omics, assay feasibility, clinical validation) (HLAAAMAA)

akta.pro secondary industries

Proteomics & Biomarker Analytical Testing (HLAGADAG), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

Keywords

• Multi-omic biomarker testing
• Personalized health assessment
• Clinical proteomics services
• Preventive health diagnostics
• Functional medicine testing

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Biomarker Testing Services: One-time testing fees for comprehensive multi-omic biomarker analysis from a single blood draw. Tests measure 250+ biomarkers with personalized health reports and actionable recommendations. Repeat testing for longitudinal tracking is encouraged every 3-12 months.
2. Clinical Laboratory Services: Partnership with HealthQuest Esoterics to run the Molecular You assay as a Lab Developed Test (LDT), making it eligible for insurance reimbursement in the US market.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Molecular You operates a multi-omic biomarker testing platform that measures 250+ proteins and metabolites from a single low-volume blood draw, using LC-MS/MS with Multiple Reaction Monitoring. AI algorithms generate pathway-level health assessments across 7 biological systems, 27+ processes, and 15 disease categories, producing personalized reports and action plans delivered through both consumer online channels and a clinical provider portal. The service includes specialized clinical modules for behavioral health and functional medicine practitioners.

Product overview

Molecular You offers a unified multi-omic biomarker testing platform centered on its core proteomics and metabolomics analysis service, which measures 190+ biomarkers from a single blood draw to assess health across 7 biological systems, 27+ processes, and 15 disease categories. The platform delivers structured reports through a Provider Portal for clinicians and Patient Reports with visual summaries for individuals. Specialized solutions include the Behavioral Health Solution evaluating neurotransmitter pathways and mental health biomarkers, and the Functional Medicine Solution supporting chronic disease assessment. The company is developing a Next-Generation Multi-Omic Assay planned to expand to 800+ biomarkers. Testing is available through direct-to-consumer channels and clinical practice partnerships, with results accessible via centralized dashboards and EHR-compatible PDF reports.

Differentiator

Problem solved

Functional benefit

Products and services

• Multi-Omic Biomarker Testing Service Core biomarker testing service that measures 250+ proteins and metabolites from a single blood draw using LC-MS/MS with Multiple Reaction Monitoring, generating AI-powered health scores and personalized action plans. Available to individual consumers via the online store and to clinicians via the Provider Portal, with use cases spanning preventive health, longevity, chronic disease monitoring, and early disease detection.
• Direct-to-Consumer Testing

Quantifiable outcome

• Detected stage 1 pancreatic cancer in a symptom-free 60-year-old woman, enabling life-saving early surgical intervention without need for additional treatment
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and flagship.

• EvosepcoreTechnology or Integration · 2 June 2026Strategic collaboration to advance standardized, high-throughput multi-omic testing. Evosep's Eno liquid chromatography system integrated into Molecular You's proteomics workflow to enable scalable, globally deployable solutions across Molecular You's international partner laboratory network, ensuring consistent CLIA-grade performance for early disease assessment.
• NPK Co., Ltd.coreStrategic or Co-development Partner · 30 January 2026MOU for precision healthcare and preventive medicine collaboration based on microbial metabolomics. Plans include joint research on microbial metabolites and biomarkers, development of functional ingredients and health foods, AI-based personalized healthcare solutions, and global market entry. NPK brings gut health and metabolic balance expertise through microbial metabolome research.
• NKCL Bio GroupflagshipStrategic or Co-development Partner · 24 September 2025MOU with South Korean biotechnology company to build AI-based bio-healthcare big data platform merging Molecular You's molecular datasets with NKCL's immune cell therapy data. First commercial deployment in Asia, establishing Korea as launchpad for regional expansion. Partnership includes third-party investment of USD 35 million into NKCL.
• HealthQuest EsotericscoreStrategic or Co-development Partner · 1 January 2024Major partnership with full-service reference laboratory to run Molecular You's assay as a Lab Developed Test (LDT), making it eligible for insurance reimbursement in the US market. Enables clinical adoption through established lab infrastructure.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• InsideTracker: InsideTracker is a direct-to-consumer biomarker testing platform that analyzes blood markers to provide personalized nutrition and longevity recommendations. Directly comparable to Molecular You's DTC multi-omic offering, with overlapping target customers (health-conscious individuals), similar action-plan delivery model, and biomarker-based health scoring.
• Function Health: Function Health offers comprehensive annual blood testing with 100+ biomarkers and personalized insights for longevity and preventive health. Direct competitor in the premium multi-biomarker DTC testing category with substantially larger funding, marketing scale, and consumer brand recognition.
• Nightingale Health: Nightingale Health provides blood-based metabolic profiling and biomarker analysis for chronic disease risk assessment using NMR-based metabolomics. Direct comparable as a multi-omic blood biomarker platform targeting preventive health and chronic disease risk, with B2B and clinical channels across Europe and beyond.

Broad incumbents

• Thorne HealthTech: Thorne is a science-focused wellness company offering at-home health testing alongside supplements and health products. Broader incumbent with overlapping biomarker testing but expanded into a wider portfolio of supplements and consumer health products.
• Quest Diagnostics: Quest Diagnostics is one of the largest clinical laboratory services companies in the US, providing routine and specialty diagnostic testing including molecular diagnostics and biomarker analysis. Comparable as a clinical lab services provider serving physicians and patients, though it operates a much broader testing portfolio at scale.
• Labcorp (Laboratory Corporation of America): Labcorp is a leading global clinical laboratory network offering routine and specialty diagnostic testing, including molecular diagnostics and esoteric biomarker panels. Comparable to Molecular You's clinical lab services arm, though vastly larger scale and broader test menu.

Emerging players

• Viome Life Sciences: Viome offers at-home gut microbiome and blood transcriptomics-based health testing with AI-driven recommendations for nutrition and wellness. Comparable DTC preventive-health testing model with multi-omic analysis (microbiome + host gene expression) but different analyte (RNA/microbiome vs proteomics/metabolomics).
• DayTwo: DayTwo provides microbiome-based personalized nutrition and blood glucose prediction for metabolic health management. Comparable emerging preventive-health testing player leveraging multi-omic (microbiome + blood) data and AI-driven recommendations, though with narrower metabolic focus.

Others

• Evosep: Evosep supplies standardized high-throughput liquid chromatography systems for clinical proteomics workflows. Comparable as a strategic technology partner to Molecular You (Eno system integrated into MY's proteomics workflow) and serves adjacent clinical proteomics customers.
• HealthQuest Esoterics: HealthQuest Esoterics is a full-service reference laboratory running Molecular You's assay as a Lab Developed Test in the US. Channel partner comparable as a clinical lab infrastructure provider, not a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/molecularyou
• Facebookfacebook.com/molecular-you-1225592607501693

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molecular You